Skip to main content
Top
Published in: Diabetes Therapy 1/2017

Open Access 01-02-2017 | Original Research

Fear of Self-Injecting and Self-Testing and the Related Risk Factors in Adolescents with Type 1 Diabetes: A Cross-Sectional Study

Authors: Ayman A. Al Hayek, Asirvatham A. Robert, Saleha Babli, Khuloud Almonea, Mohamed A. Al Dawish

Published in: Diabetes Therapy | Issue 1/2017

Login to get access

Abstract

Introduction

This study was conducted to investigate the fear of self-injecting and self-testing and its related risk factors among adolescents with type 1 diabetes mellitus (T1DM).

Methods

From December 2015 to April 2016, a cross-sectional study was performed at the Diabetes Treatment Center, Prince Sultan Military Medical City, Riyadh, Saudi Arabia on 142 registered T1DM patients between 13 and 19 years of age. Selection of the respondents was done deliberately and carefully, and the suitable patients were given specific identification numbers. A trained interviewer administered the short Diabetes Fear of Injecting and Self-testing Questionnaire to each patient. It included two subscales estimating the fear of self-injection (FSI) and fear of self-testing (FST). Each patient’s age, gender, weight, height, adjusted body mass index (BMI), duration of the diabetic condition, treatment modality, insulin dosage, and glycosylated hemoglobin (HbA1c) were recorded.

Results

The study found that the overall mean score of FSI was 2.44 ± 0.96, whereas that of FST was 2.25 ± 1.04. Adolescents above 16 years of age, treated with multiple daily insulin (MDI), on higher insulin doses, having poor glycemic control, and fewer finger pricks were observed to show significant risk factors for fear of self-injection of insulin, whereas in those patients having a long duration of T1DM, MDI treated, on higher insulin doses, with poor glycemic control, and fewer finger pricks showed significant risk factors for fear of self-testing of blood glucose. From the regression analysis it was evident that the variables of higher age, MDI treatment, and fewer finger pricks were independent risk factors for fear of self-injection of the insulin, whereas a fewer number of finger pricks was an independent risk factor for fear of self-testing the blood glucose.

Conclusion

Fear of self-injecting and fear of self-testing are common among adolescents with T1DM. Therefore, it is essential to ensure comprehensive multidisciplinary diabetes education to lower the risk factor of fear of injections.
Literature
1.
go back to reference Al Dawish MA, Robert AA, Braham R, Al Hayek AA, Al Saeed A, Ahmed RA, Al Sabaan FS. Diabetes mellitus in Saudi Arabia: a review of the recent literature. Curr Diabetes Rev. 2016;12:359–68. Al Dawish MA, Robert AA, Braham R, Al Hayek AA, Al Saeed A, Ahmed RA, Al Sabaan FS. Diabetes mellitus in Saudi Arabia: a review of the recent literature. Curr Diabetes Rev. 2016;12:359–68.
2.
go back to reference Lloyd B, Groat D, Cook CB, Kaufman D, Grando A. iDECIDE: a mobile application for insulin dosing using an evidence based equation to account for patient preferences. Stud Health Technol Inform. 2015;216:93–7.PubMedPubMedCentral Lloyd B, Groat D, Cook CB, Kaufman D, Grando A. iDECIDE: a mobile application for insulin dosing using an evidence based equation to account for patient preferences. Stud Health Technol Inform. 2015;216:93–7.PubMedPubMedCentral
3.
go back to reference Steil GM, Alexander J, Papas A, et al. Use of a continuous glucose sensor in an extracorporeal life support circuit. J Diabetes Sci Technol. 2011;5:93–8.CrossRefPubMedPubMedCentral Steil GM, Alexander J, Papas A, et al. Use of a continuous glucose sensor in an extracorporeal life support circuit. J Diabetes Sci Technol. 2011;5:93–8.CrossRefPubMedPubMedCentral
4.
go back to reference Cemeroglu AP, Can A, Davis AT, et al. Fear of needles in children with type 1 diabetes mellitus on multiple daily injections and continuous subcutaneous insulin infusion. Endocr Pract. 2015;21:46–53.CrossRefPubMed Cemeroglu AP, Can A, Davis AT, et al. Fear of needles in children with type 1 diabetes mellitus on multiple daily injections and continuous subcutaneous insulin infusion. Endocr Pract. 2015;21:46–53.CrossRefPubMed
5.
go back to reference Fu AZ, Qiu Y, Radican L. Impact of fear of insulin or fear of injection on treatment outcomes of patients with diabetes. Curr Med Res Opin. 2009;25:1413–20.CrossRefPubMed Fu AZ, Qiu Y, Radican L. Impact of fear of insulin or fear of injection on treatment outcomes of patients with diabetes. Curr Med Res Opin. 2009;25:1413–20.CrossRefPubMed
6.
go back to reference Mollema ED, Snoek FJ, Pouwer F, Heine RJ, van der Ploeg HM. Diabetes fear of injecting and self-testing questionnaire: a psychometric evaluation. Diabetes Care. 2000;23(6):765–9.CrossRefPubMed Mollema ED, Snoek FJ, Pouwer F, Heine RJ, van der Ploeg HM. Diabetes fear of injecting and self-testing questionnaire: a psychometric evaluation. Diabetes Care. 2000;23(6):765–9.CrossRefPubMed
7.
go back to reference Berlin I, Bisserbe JC, Eiber R, et al. Phobic symptoms, particularly the fear of blood and injury, are associated with poor glycemic control in type I diabetic adults. Diabetes Care. 1997;20:176–8.CrossRefPubMed Berlin I, Bisserbe JC, Eiber R, et al. Phobic symptoms, particularly the fear of blood and injury, are associated with poor glycemic control in type I diabetic adults. Diabetes Care. 1997;20:176–8.CrossRefPubMed
8.
go back to reference Metsch J, Tillil H, Kobberling J, Sartory G. On the relation among psychological distress, diabetes-related health behavior, and level of glycosylated hemoglobin in type I diabetes. Int J Behav Med. 1995;2:104–17.CrossRefPubMed Metsch J, Tillil H, Kobberling J, Sartory G. On the relation among psychological distress, diabetes-related health behavior, and level of glycosylated hemoglobin in type I diabetes. Int J Behav Med. 1995;2:104–17.CrossRefPubMed
9.
go back to reference Snoek FJ, Mollema ED, Heine RJ, Bouter LM, van der Ploeg HM. Development and validation of the diabetes fear of injecting and self-testing questionnaire (D-FISQ): first findings. Diabet Med. 1997;14:871–6.CrossRefPubMed Snoek FJ, Mollema ED, Heine RJ, Bouter LM, van der Ploeg HM. Development and validation of the diabetes fear of injecting and self-testing questionnaire (D-FISQ): first findings. Diabet Med. 1997;14:871–6.CrossRefPubMed
10.
go back to reference Fu SN, Wong CK, Chin WY, Luk W. Association of more negative attitude towards commencing insulin with lower glycosylated hemoglobin (HbA1c) level: a survey on insulin-naive type 2 diabetes mellitus Chinese patients. J Diabetes Metab Disord. 2015;15:3.CrossRefPubMed Fu SN, Wong CK, Chin WY, Luk W. Association of more negative attitude towards commencing insulin with lower glycosylated hemoglobin (HbA1c) level: a survey on insulin-naive type 2 diabetes mellitus Chinese patients. J Diabetes Metab Disord. 2015;15:3.CrossRefPubMed
11.
go back to reference Nam S, Chesla C, Stotts NA, Kroon L, Janson SL. Factors associated with psychological insulin resistance in individuals with type 2 diabetes. Diabetes Care. 2010;33(8):1747–9.CrossRefPubMedPubMedCentral Nam S, Chesla C, Stotts NA, Kroon L, Janson SL. Factors associated with psychological insulin resistance in individuals with type 2 diabetes. Diabetes Care. 2010;33(8):1747–9.CrossRefPubMedPubMedCentral
13.
go back to reference Howe CJ, Ratcliffe SJ, Tuttle A, Dougherty S, Lipman TH. Needle anxiety in children with type 1 diabetes and their mothers. Am J Matern Child Nurs. 2011;36:25–31.CrossRef Howe CJ, Ratcliffe SJ, Tuttle A, Dougherty S, Lipman TH. Needle anxiety in children with type 1 diabetes and their mothers. Am J Matern Child Nurs. 2011;36:25–31.CrossRef
14.
go back to reference Simmons JH, McFann KK, Brown AC, et al. Reliability of the Diabetes Fear of Injecting and Self-Testing Questionnaire in pediatric patients with type 1 diabetes. Diabetes Care. 2007;30:987–8.CrossRefPubMed Simmons JH, McFann KK, Brown AC, et al. Reliability of the Diabetes Fear of Injecting and Self-Testing Questionnaire in pediatric patients with type 1 diabetes. Diabetes Care. 2007;30:987–8.CrossRefPubMed
15.
go back to reference Davis WA, Bruce DG, Davis TM. Is self-monitoring of blood glucose appropriate for all type 2 diabetic patients? The Fremantle Diabetes Study. Diabetes Care. 2006;29:1764–70.CrossRefPubMed Davis WA, Bruce DG, Davis TM. Is self-monitoring of blood glucose appropriate for all type 2 diabetic patients? The Fremantle Diabetes Study. Diabetes Care. 2006;29:1764–70.CrossRefPubMed
16.
go back to reference Nyomba BL, Berard L, Murphy LJ. The cost of self-monitoring of blood glucose is an important factor limiting glycemic control in diabetic patients. Diabetes Care. 2002;25:1244–5.CrossRefPubMed Nyomba BL, Berard L, Murphy LJ. The cost of self-monitoring of blood glucose is an important factor limiting glycemic control in diabetic patients. Diabetes Care. 2002;25:1244–5.CrossRefPubMed
17.
go back to reference Bangstad HJ, Danne T, Deeb L, Jarosz-Chobot P, Urakami T, Hanas R. Insulin treatment in children and adolescents with diabetes. Pediatr Diabetes. 2009;10(Suppl 12):82–99.CrossRefPubMed Bangstad HJ, Danne T, Deeb L, Jarosz-Chobot P, Urakami T, Hanas R. Insulin treatment in children and adolescents with diabetes. Pediatr Diabetes. 2009;10(Suppl 12):82–99.CrossRefPubMed
18.
go back to reference Ong WM, Chua SS, Ng CJ. Barriers and facilitators to self-monitoring of blood glucose in people with type 2 diabetes using insulin: a qualitative study. Patient Prefer Adherence. 2014;8:237–46.PubMedPubMedCentral Ong WM, Chua SS, Ng CJ. Barriers and facilitators to self-monitoring of blood glucose in people with type 2 diabetes using insulin: a qualitative study. Patient Prefer Adherence. 2014;8:237–46.PubMedPubMedCentral
19.
go back to reference Khan AR, Al-Abdul Lateef ZN, Al Aithan MA, Bu-Khamseen MA, Al Ibrahim I, Khan SA. Factors contributing to non-compliance among diabetics attending primary health centers in the Al Hasa district of Saudi Arabia. J Fam Community Med. 2012;19:26–32.CrossRef Khan AR, Al-Abdul Lateef ZN, Al Aithan MA, Bu-Khamseen MA, Al Ibrahim I, Khan SA. Factors contributing to non-compliance among diabetics attending primary health centers in the Al Hasa district of Saudi Arabia. J Fam Community Med. 2012;19:26–32.CrossRef
22.
go back to reference Al Hayek AA, Robert AA, Al Dawish MA, Braham RB, Goudeh HS, Al Sabaan FS. Efficacy of insulin pump therapy on diabetes treatment satisfaction and glycemic control among patients with type 1 diabetes mellitus in Saudi Arabia: a prospective study. Diabetes Ther. 2015;6:227–36.CrossRefPubMedPubMedCentral Al Hayek AA, Robert AA, Al Dawish MA, Braham RB, Goudeh HS, Al Sabaan FS. Efficacy of insulin pump therapy on diabetes treatment satisfaction and glycemic control among patients with type 1 diabetes mellitus in Saudi Arabia: a prospective study. Diabetes Ther. 2015;6:227–36.CrossRefPubMedPubMedCentral
23.
go back to reference Al Hayek AA, Robert AA, Al Dawish M, Ahmed RA, Al Sabaan FS. The Evolving role of short-term professional continuous glucose monitoring on glycemic control and hypoglycemia among Saudi patients with type 1 diabetes: a prospective study. Diabetes Ther. 2015;6:329–37.CrossRefPubMedPubMedCentral Al Hayek AA, Robert AA, Al Dawish M, Ahmed RA, Al Sabaan FS. The Evolving role of short-term professional continuous glucose monitoring on glycemic control and hypoglycemia among Saudi patients with type 1 diabetes: a prospective study. Diabetes Ther. 2015;6:329–37.CrossRefPubMedPubMedCentral
24.
go back to reference Harris MI, Cowie CC, Howie LJ. Self-monitoring of blood glucose by adults with diabetes in the United States population. Diabetes Care. 1993;16:1116–23.CrossRefPubMed Harris MI, Cowie CC, Howie LJ. Self-monitoring of blood glucose by adults with diabetes in the United States population. Diabetes Care. 1993;16:1116–23.CrossRefPubMed
25.
go back to reference Scorpiglione N, El-Shazly M, Abdel-Fattah M, et al. Epidemiology and determinants of blood glucose self-monitoring in clinical practice. Diabetes Res Clin Pract. 1996;34:115–25.CrossRefPubMed Scorpiglione N, El-Shazly M, Abdel-Fattah M, et al. Epidemiology and determinants of blood glucose self-monitoring in clinical practice. Diabetes Res Clin Pract. 1996;34:115–25.CrossRefPubMed
26.
go back to reference Mastura I, Mimi O, Piterman L, Teng CL, Wijesinha S. Self-monitoring of blood glucose among diabetes patients attending government health clinics. Med J Malaysia. 2007;62:147–51.PubMed Mastura I, Mimi O, Piterman L, Teng CL, Wijesinha S. Self-monitoring of blood glucose among diabetes patients attending government health clinics. Med J Malaysia. 2007;62:147–51.PubMed
Metadata
Title
Fear of Self-Injecting and Self-Testing and the Related Risk Factors in Adolescents with Type 1 Diabetes: A Cross-Sectional Study
Authors
Ayman A. Al Hayek
Asirvatham A. Robert
Saleha Babli
Khuloud Almonea
Mohamed A. Al Dawish
Publication date
01-02-2017
Publisher
Springer Healthcare
Published in
Diabetes Therapy / Issue 1/2017
Print ISSN: 1869-6953
Electronic ISSN: 1869-6961
DOI
https://doi.org/10.1007/s13300-016-0221-8

Other articles of this Issue 1/2017

Diabetes Therapy 1/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.